Serological surveillance of SARS-CoV-2: Six-month trends and antibody response in a cohort of public health workers
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
Article activity feed
-
-
-
SciScore for 10.1101/2020.10.21.20216689: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement Consent: After providing written consent, participants completed a brief questionnaire about recent respiratory symptoms and provided ∼10 mL of blood by venepuncture. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Antibodies Sentences Resources Study design: ESCAPE (Enhanced SeroIncidence for COVID-19 Antibodies among PHE and NHS Staff) is a prospective surveillance cohort collecting blood samples for SARS-CoV-2 antibodies and questionnaire data at monthly intervals. SARS-CoV-2suggested: NoneResults from OddPub: We did not detect open data. We also did not detect open code. …
SciScore for 10.1101/2020.10.21.20216689: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement Consent: After providing written consent, participants completed a brief questionnaire about recent respiratory symptoms and provided ∼10 mL of blood by venepuncture. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Antibodies Sentences Resources Study design: ESCAPE (Enhanced SeroIncidence for COVID-19 Antibodies among PHE and NHS Staff) is a prospective surveillance cohort collecting blood samples for SARS-CoV-2 antibodies and questionnaire data at monthly intervals. SARS-CoV-2suggested: NoneResults from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-